Trademark: 97512329
Word
AMERIPHARMA
Status Date
Tuesday, March 26, 2024
Filing Date
Wednesday, July 20, 2022
Published for Opposition
Tuesday, March 26, 2024
5 Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
35 Mail order pharmacy services; Retail pharmacy services
The mark consists of a horizontal DNA double helix created with the use of dots, connected by straight lines that lead into and surround the first two letters of AmeriPharma which is written in standard font.
AMERICA PHARMACY
Color is not claimed as a feature of the mark.
Mar 26, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 26, 2024
Published For Opposition
Mar 6, 2024
Notification Of Notice Of Publication E-Mailed
Mar 6, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 21, 2024
Approved For Pub - Principal Register
Jan 17, 2024
Teas/Email Correspondence Entered
Jan 16, 2024
Correspondence Received In Law Office
Jan 16, 2024
Teas Request For Reconsideration Received
Nov 3, 2023
Notification Of Final Refusal Emailed
Nov 3, 2023
Final Refusal E-Mailed
Nov 3, 2023
Final Refusal Written
Oct 7, 2023
Teas/Email Correspondence Entered
Oct 6, 2023
Correspondence Received In Law Office
Oct 6, 2023
Teas Response To Office Action Received
Jun 29, 2023
Application Extension Granted/Receipt Provided
Jun 29, 2023
Application Extension To Response Period - Received
Apr 8, 2023
Notification Of Non-Final Action E-Mailed
Apr 8, 2023
Non-Final Action E-Mailed
Apr 8, 2023
Non-Final Action Written
Mar 29, 2023
Assigned To Examiner
Aug 11, 2022
Notice Of Design Search Code E-Mailed
Aug 10, 2022
New Application Office Supplied Data Entered
Jul 23, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
